4//SEC Filing
Ribeiro Ramiro 4
Accession 0002013623-25-000005
CIK 0001314102other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:03 PM ET
Size
5.7 KB
Accession
0002013623-25-000005
Insider Transaction Report
Form 4
Ribeiro Ramiro
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-11-11$11.61/sh−2,722$31,602→ 0 total
Footnotes (2)
- [F1]Amount sold consists of 2,722 shares acquired on January 31, 2025, pursuant to EyePoint's 2019 Employee Stock Purchase Plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.30 to $11.75. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0002013623
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 4:03 PM ET
- Size
- 5.7 KB